License was Lexicon Pharmaceuticals’s largest product and service line in fiscal 2025, bringing in $45.00M of $49.65M (91%).
| Product and Service | FY 2024 | FY 2025 |
|---|---|---|
| License | $25.00M | $45.00M |
| Product | $6.00M | $4.65M |
| Total | $31.00M | $49.65M |
Lexicon Pharmaceuticals brought in $49.65M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 60.1% from $31.00M in fiscal 2024. License was the largest at $45.00M (90.6%), ahead of Product at $4.65M (9.4%).
Compared with fiscal 2024, License grew 80.0% to $45.00M, while Product fell 22.6% to $4.65M.
Previously Reported was Lexicon Pharmaceuticals’s largest revenue line in fiscal 2017, bringing in $90.34M of $91.69M (99%).
| Restatement | FY 2016 | FY 2017 |
|---|---|---|
| Previously Reported | $83.34M | $90.34M |
| Adjustments | -$4.08M | $1.35M |
| Total | $79.26M | $91.69M |
Lexicon Pharmaceuticals brought in $91.69M from its two revenue lines in fiscal 2017, the year ended December 31, 2017. That was up 15.7% from $79.26M in fiscal 2016. Previously Reported was the largest at $90.34M (98.5%), ahead of Adjustments at $1.35M (1.5%).
Lexicon Pharmaceuticals (LXRX) reports its revenue by product and service and by restatement. In fiscal 2025, License was its largest product and service line, bringing in $45.00M (90.6% of the total), followed by Product at $4.65M (9.4%).
License was Lexicon Pharmaceuticals' largest product and service line in fiscal 2025, bringing in $45.00M, or 90.6% of the $49.65M total across its two product and service lines.
Previously Reported was Lexicon Pharmaceuticals' largest revenue line in fiscal 2017, bringing in $90.34M, or 98.5% of the $91.69M total across its two revenue lines.
License grew faster than Product in fiscal 2025, up 80.0% from $25.00M to $45.00M. Product fell 22.6% to $4.65M.
Every figure comes from Lexicon Pharmaceuticals' annual financial filings, as reported. Each line keeps the name Lexicon Pharmaceuticals gives it, and years follow its fiscal calendar.
Lexicon Pharmaceuticals' revenue by product and service goes back to fiscal 2024, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.